Cumberland Pharmaceuticals (CPIX) Other Operating Expenses (2010 - 2026)

Cumberland Pharmaceuticals has disclosed Other Operating Expenses across 17 years of filings, most recently posting $7151.0 for Q2 2026.

• In Q2 2026, Other Operating Expenses rose 23.96% year-over-year to $7151.0; the TTM figure through Jun 2026 stood at $12.7 million (up 4.41% YoY), while the FY2025 annual figure was $16.3 million, changed N/A from the prior year.
• Other Operating Expenses came in at $7151.0 for Q2 2026 at Cumberland Pharmaceuticals, down from $4.6 million in the prior quarter.
• In the past five years, Other Operating Expenses ranged from a high of $7.3 million in Q4 2023 to a low of $5769.0 in Q2 2025.
• Average Other Operating Expenses over 5 years is $4.1 million, with a median of $4.2 million recorded in 2022.
• Year-over-year, Other Operating Expenses surged 62.46% in 2023 and sank 99.85% in 2025.
• Over 5 years, Other Operating Expenses stood at $4.5 million in 2022, then surged by 62.46% to $7.3 million in 2023, then tumbled by 35.52% to $4.7 million in 2024, then gained by 1.6% to $4.8 million in 2025, then plunged by 99.85% to $7151.0 in 2026.
• Per Business Quant data, the three most recent Other Operating Expenses figures were $7151.0 in Q2 2026, $4.6 million in Q1 2026, and $4.8 million in Q4 2025.